These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3220102)

  • 21. Enhancement of monocyte complement component synthesis by antigen--antibody complexes.
    McPhaden A; Lappin D; Whaley K
    Immunology; 1981 Sep; 44(1):193-200. PubMed ID: 7275185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secretory component-dependent hepatic transport of IgA antibody-antigen complexes.
    Socken DJ; Simms ES; Nagy BR; Fisher MM; Underdown BJ
    J Immunol; 1981 Jul; 127(1):316-9. PubMed ID: 7240746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
    Garred P; Michaelsen TE; Aase A; Mollnes TE
    J Immunol; 1990 Jan; 144(1):198-203. PubMed ID: 2295791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of immune precipitation by complement.
    Schifferli JA; Bartolotti SR; Peters DK
    Clin Exp Immunol; 1980 Nov; 42(2):387-94. PubMed ID: 6781802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of complement-dependent phagocytosis by monocytes following pre-incubation with immune complexes and interaction with plasma.
    Pinching AJ
    Clin Exp Immunol; 1983 Jan; 51(1):83-90. PubMed ID: 6831773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of H chain V region on complement activation by immobilized immune complexes.
    Horgan C; Brown K; Pincus SH
    J Immunol; 1992 Jul; 149(1):127-35. PubMed ID: 1607649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An IgA monoclonal antibody directed against type III antigen on group B streptococci acts as an opsonin.
    Bohnsack JF; Hawley MM; Pritchard DG; Egan ML; Shigeoka AO; Yang KD; Hill HR
    J Immunol; 1989 Nov; 143(10):3338-42. PubMed ID: 2681414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of persistent IgA/IgG circulating immune complexes associated with activation of the complement system in serum of a patient with common variable immune deficiency: anaphylactic reactions to intravenous gammaglobulin.
    Wahn V; Good RA; Gupta S; Pahwa S; Day NK
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():49-58. PubMed ID: 6203331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical alterations in macrophages by interaction with immune complexes.
    Anand V; Srivastava LM
    Indian J Exp Biol; 1996 Apr; 34(4):307-10. PubMed ID: 8698418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of low m.w., C3-bearing immunoglobulin in human serum.
    Jacobs RJ; Reichlin M
    J Immunol; 1983 Jun; 130(6):2775-81. PubMed ID: 6602181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the mechanism producing solubilization of immune precipitates in the serum of patients with primary IgA nephropathy.
    Schena FP; Pastore A; Sinico RA; Ladisa N; Montinaro V; Fornasieri A
    Semin Nephrol; 1987 Dec; 7(4):336-40. PubMed ID: 3445011
    [No Abstract]   [Full Text] [Related]  

  • 33. Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo.
    de Jong JM; Schuurhuis DH; Ioan-Facsinay A; van der Voort EI; Huizinga TW; Ossendorp F; Toes RE; Verbeek JS
    Mol Immunol; 2006 May; 43(13):2045-50. PubMed ID: 16513171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial transcytosis of monomeric IgA and IgG cross-linked through antigen to polymeric IgA. A role for monomeric antibodies in the mucosal immune system.
    Kaetzel CS; Robinson JK; Lamm ME
    J Immunol; 1994 Jan; 152(1):72-6. PubMed ID: 8254208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement enhances the clearance of large-sized soluble IgA aggregates in rats.
    Bogers WM; Stad RK; Janssen DJ; Rits M; Bazin H; Van Es LA; Daha MR
    Eur J Immunol; 1991 May; 21(5):1093-9. PubMed ID: 2037008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes.
    Pfaffenbach G; Lamm ME; Gigli I
    J Exp Med; 1982 Jan; 155(1):231-47. PubMed ID: 7054357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analyses of C3b capture and immune adherence of IgM antibody/dsDNA immune complexes.
    Taylor RP; Wright EL; Pocanic F
    J Immunol; 1989 Dec; 143(11):3626-31. PubMed ID: 2584711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
    Horgan C; Burge J; Crawford L; Taylor RP
    J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune adherence and staphylococcus protein A binding of soluble immune complexes produced by complement activation.
    Schifferli JA; Peters DK
    Clin Exp Immunol; 1983 Dec; 54(3):827-33. PubMed ID: 6228359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.